IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer

Yinghui Zhang1, Lynn Wester2, Jichao He2

  • 1Division of Toxicology, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands. y.zhang@lacdr.leidenuniv.nl.

Oncogene
|January 23, 2018
PubMed

Insights

Insulin-like growth factor 1 receptor (IGF1R) drives antiestrogen resistance in ER-positive breast cancer. The p21-activated kinase 2 (PAK2) pathway is identified as a key driver, suggesting new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Antiestrogen resistance limits treatment efficacy in estrogen receptor-positive (ER+) breast cancer.
  • Increased insulin-like growth factor 1 receptor (IGF1R) signaling is a known mechanism contributing to this resistance.

Purpose of the Study:

  • To identify key regulators of IGF1R-mediated antiestrogen resistance using a kinome siRNA screen.
  • To elucidate the role of identified regulators, particularly p21-activated kinase 2 (PAK2), in resistance mechanisms.
  • To investigate the downstream signaling of IGF1R in the context of antiestrogen resistance.

Main Methods:

  • Genome-wide kinome siRNA screen to identify regulators of IGF1R signaling.
  • Gene silencing experiments (siRNA) to assess the impact of identified regulators on tamoxifen and fulvestrant resistance.
  • Phospho-proteomics to define downstream signaling targets of IGF1R.
  • Analysis of patient data correlating gene expression with clinical outcomes.

Main Results:

  • A screen identified 10 regulators of IGF1R-mediated antiestrogen resistance, including suppressors and inducers.
  • p21-activated kinase 2 (PAK2) was identified as the strongest resistance inducer; its silencing sensitized cells to antiestrogens.
  • PAK2 and PAK-interacting exchange factors (PIXα/β) were identified as downstream IGF1R targets, independent of PI3K/Akt and MAPK/ERK pathways.
  • High PAK2 expression in ER+ metastatic breast cancer patients correlated with poor outcomes after tamoxifen therapy.

Conclusions:

  • The PAK2/PIX pathway is a critical effector in IGF1R-mediated antiestrogen resistance in ER+ breast cancer.
  • Targeting PAK2 or PIX demonstrates potential for overcoming antiestrogen resistance.
  • These findings highlight a novel therapeutic strategy for resistant ER+ breast cancer.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Energy to Drive Translocation01:37

Energy to Drive Translocation

Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
2.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.6K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.1K